Q2 2018

Portfolio Performance – Q2 2018

For those of you in a rush, portfolio returns year to date have been 3.19% against my benchmark (FTSE All-Share TR) having returned 1.69%.  So the good news is, in this second quarter I’ve swung from a 10% negative return to a 3% positive return.  Since inception in August 2015 the portfolio has returned 70.55% against 22.30% for the All-Share.  Therefore the compound annual return for my portfolio is 20.09% going into my fourth year of investing.  You can view the portfolio here.

Continue reading “Portfolio Performance – Q2 2018”

Van Elle

Van Elle Holdings – A Somero Replacement?

I loves a bargain.  Running my screen recently led me to Van Elle Holdings PLC, a company definitely meeting that criteria.  Van Elle currently trades at a shade over seven times earnings, and only 0.67 times sales.  It yields approximately 3.6% as well.  But does it warrant a purchase?  I’m going to enlist the help of one of my current holdings to try and find out.

Continue reading “Van Elle Holdings – A Somero Replacement?”

AMS

AMS – Big Returns Require Patience

I had a brief chat with @wheeliedealer the other day on Twitter.  I was responding to a post of his, in which he shared a chart of one of my holdings, Advanced Medical Solutions (LSE: AMS):

Continue reading “AMS – Big Returns Require Patience”

Q1 2018

Portfolio Performance – Q1 2018

Oh 2017, how I long to have you back.  In truth, the value of the portfolio topped out in November of last year, and has been falling steadily since.  Total return year to date in 2018 has been -10.02% against the FTSE All-Share TR of –6.87%.  I’m falling behind my benchmark, which is very disappointing.  However, nothing will be changing as a result.  I’ve been here before.  I’ll be here again.  Total return since inception is a more pleasing 51.79%, against a 27.8% increase for the FTSE All-Share.  So I’m well ahead of the benchmark since inception.  That’s the important thing.  You can view the portfolio here.

Continue reading “Portfolio Performance – Q1 2018”